Prognostic value of circulating tumor DNA (ctDNA) testing in patients (pts) with rectal cancer after neoadjuvant therapy (NAT) and surgery. Meeting Abstract

Industry Collaboration

cited authors

  • Chakrabarti, Sakti; Cohen, Stacey A.; Tin, Antony; Dangl, Autumn; Aushev, Vasily N.; Tejani, Mohamedtaki Abdulaziz; Chandana, Sreenivasa R.; Malla, Midhun; Landmann, Ron G.; Sharma, Vivek R.; Botta, Gregory P.; Nagarajan, Arun; Azzi, Georges; Cho, May Thet; Dayyani, Farshid; Hanna, Diana L.; Jurdi, Adham A.; Liu, Minetta C.; Dasari, Arvind; Kasi, Pashtoon Murtaza

Publication Date

  • January 20, 2024

webpage

published in

category

keywords

  • 2
  • 227-201-3614
  • 261-492-3532-2370-7650-2454
  • 261-492-5651-5654
  • 281-206-4760-6705
  • 281-318-6655
  • 283-237-255-1133
  • 3
  • 6
  • 613-4678-146
  • 8

start page

  • 212

end page

  • 212

volume

  • 42

issue

  • 3_SUPPL